Bristol-Myers Squibb Company (BMY) earnings
BMY earnings moved a median of +0.22% by the close. Quarterly and annual BMY reports and results, each read against the price at its own news timestamp. Back to the BMY overview →
24 measured BMY earnings events.
Where these BMY earnings landedvs 24 measured BMY earnings reactions
| Middle 50% of BMY earnings reactions | -0.93% to +0.89% |
|---|---|
| Median reaction (to close) | +0.22% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 BMY earnings events with a measured close landed between -0.93% and +0.89%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bristol Myers Squibb to Report Results for Third Quarter 2026 on October 29, 2026 | Press release | +0.13% | +0.56% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30 | SEC filing · Form 10-Q | -0.13% | +2.08% | |
| Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026 | Press release | -0.72% | -2.10% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Mar 31 | SEC filing · Form 10-Q | -0.06% | +0.38% | |
| Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026 | Press release | +0.44% | -1.91% | |
| Form 10-K BRISTOL MYERS SQUIBB CO For: Dec 31 | SEC filing · Form 10-K | -0.12% | -1.69% | |
| Bristol Myers Squibb to Report Results for Fourth Quarter 2025 on February 5, 2026 | Press release | +0.94% | +0.24% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30 | SEC filing · Form 10-Q | +0.20% | +0.85% | |
| Bristol Myers Squibb to Report Results for Third Quarter 2025 on October 30, 2025 | Press release | -0.36% | -1.57% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30 | SEC filing · Form 10-Q | -0.07% | -0.92% | |
| Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025 | Press release | +0.09% | +1.06% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Mar 31 | SEC filing · Form 10-Q | -0.05% | +1.02% | |
| Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025 | Press release | -0.28% | +0.25% | |
| Form 10-K BRISTOL MYERS SQUIBB CO For: Dec 31 | SEC filing · Form 10-K | -0.03% | +0.20% | |
| Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025 | Press release | +0.41% | -0.97% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30 | SEC filing · Form 10-Q | -0.20% | +1.85% | |
| Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024 | Press release | +0.26% | -0.29% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Jun 30 | SEC filing · Form 10-Q | -0.06% | +1.83% | |
| Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024 | Press release | +0.37% | +1.21% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Mar 31 | SEC filing · Form 10-Q | +0.11% | -0.02% | |
| Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024 | Press release | -0.42% | +0.13% | |
| Form 10-K BRISTOL MYERS SQUIBB CO For: Dec 31 | SEC filing · Form 10-K | -0.06% | +0.35% | |
| Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024 | Press release | -0.37% | -0.53% | |
| Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30 | SEC filing · Form 10-Q | -0.07% | -1.30% |
Keep exploring
More BMY: analyst actions → · SEC filings → · BMY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sierra Oncology, Inc. (SRRA) | 649 | -0.03% | 43% |
| Catabasis Pharmaceuticals, Inc. (CATB) | 647 | -0.14% | 45% |
| Five Star Senior Living Inc. - Common Shares (FVE) | 642 | 0.00% | 44% |
| Apollo Endosurgery, Inc. (APEN) | 640 | 0.00% | 47% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.